IDEXX Laboratories, Inc. (IDXX)
515.21
-11.86
(-2.25%)
USD |
NASDAQ |
Oct 06, 16:00
515.21
0.00 (0.00%)
After-Hours: 19:41
IDEXX Laboratories Cash from Operations (Quarterly) : 347.16M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 347.16M |
| March 31, 2026 | 266.25M |
| December 31, 2025 | 352.02M |
| September 30, 2025 | 402.34M |
| June 30, 2025 | 185.74M |
| March 31, 2025 | 237.96M |
| December 31, 2024 | 262.02M |
| September 30, 2024 | 220.08M |
| June 30, 2024 | 248.31M |
| March 31, 2024 | 198.58M |
| December 31, 2023 | 249.85M |
| September 30, 2023 | 272.43M |
| June 30, 2023 | 200.31M |
| March 31, 2023 | 183.91M |
| December 31, 2022 | 172.99M |
| September 30, 2022 | 189.00M |
| June 30, 2022 | 65.85M |
| March 31, 2022 | 114.71M |
| December 31, 2021 | 207.31M |
| September 30, 2021 | 187.20M |
| June 30, 2021 | 233.96M |
| March 31, 2021 | 124.42M |
| December 31, 2020 | 218.93M |
| September 30, 2020 | 193.12M |
| June 30, 2020 | 208.14M |
| Date | Value |
|---|---|
| March 31, 2020 | 27.87M |
| December 31, 2019 | 155.41M |
| September 30, 2019 | 132.26M |
| June 30, 2019 | 137.10M |
| March 31, 2019 | 34.38M |
| December 31, 2018 | 135.65M |
| September 30, 2018 | 110.71M |
| June 30, 2018 | 118.83M |
| March 31, 2018 | 34.90M |
| December 31, 2017 | 121.13M |
| September 30, 2017 | 110.68M |
| June 30, 2017 | 110.19M |
| March 31, 2017 | 31.27M |
| December 31, 2016 | 100.12M |
| September 30, 2016 | 100.32M |
| June 30, 2016 | 110.92M |
| March 31, 2016 | 23.17M |
| December 31, 2015 | 73.90M |
| September 30, 2015 | 76.95M |
| June 30, 2015 | 80.17M |
| March 31, 2015 | -14.64M |
| December 31, 2014 | 27.30M |
| September 30, 2014 | 93.26M |
| June 30, 2014 | 81.76M |
| March 31, 2014 | 33.52M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Neogen Corp. | 30.20M |
| QuidelOrtho Corp. | -110.60M |
| Aspira Women's Health, Inc. | -2.01M |
| VolitionRX Ltd. | -4.993M |
| Lucid Diagnostics, Inc. | -11.30M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -25.50M |
| Cash from Financing (Quarterly) | -325.19M |
| Free Cash Flow | 1.233B |
| Free Cash Flow Per Share (Quarterly) | 4.043 |
| Free Cash Flow to Equity (Quarterly) | 329.99M |
| Free Cash Flow to Firm (Quarterly) | 329.92M |
| Free Cash Flow Yield | 2.99% |